ACEON Drug Patent Profile
✉ Email this page to a colleague
When do Aceon patents expire, and what generic alternatives are available?
Aceon is a drug marketed by Symplmed Pharms Llc and is included in one NDA.
The generic ingredient in ACEON is perindopril erbumine. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the perindopril erbumine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aceon
A generic version of ACEON was approved as perindopril erbumine by AUROBINDO PHARMA on November 10th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACEON?
- What are the global sales for ACEON?
- What is Average Wholesale Price for ACEON?
Summary for ACEON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 1,983 |
What excipients (inactive ingredients) are in ACEON? | ACEON excipients list |
DailyMed Link: | ACEON at DailyMed |
![ACEON drug patent expirations Drug patent expirations by year for ACEON](/p/graph/s/t/ACEON-patent-expirations.png)
Paragraph IV (Patent) Challenges for ACEON
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ACEON | Tablets | perindopril erbumine | 2 mg, 4 mg and 8 mg | 020184 | 1 | 2006-06-06 |
US Patents and Regulatory Information for ACEON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-001 | Dec 30, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-002 | Dec 30, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-003 | Dec 30, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACEON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-003 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-001 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Symplmed Pharms Llc | ACEON | perindopril erbumine | TABLET;ORAL | 020184-002 | Dec 30, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ACEON
See the table below for patents covering ACEON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 830006219 | ⤷ Sign Up | |
New Zealand | 198535 | SUBSTITUTED AZABICYCLOALKANEDICARBOXYLIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH | ⤷ Sign Up |
Japan | H07121955 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ACEON
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0049658 | SPC/GB93/141 | United Kingdom | ⤷ Sign Up | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |